Indian Pharma's Fraudulent Job Applicants
Thirty-five out of every 100 job applicants in the pharmaceutical or clinical trial space in India “are lying about their credentials”, says a report by Delhi-based employee screening firm AuthBridge.
Thirty-five out of every 100 job applicants in the pharmaceutical or clinical trial space in India “are lying about their credentials”, says a report by Delhi-based employee screening firm AuthBridge.
According to a report in India’s Economic Times, AuthBridge sifted through three years of applicant data from over 500 companies and found that pharma/clinical trials is among the industries with the “highest employee discrepancies”.
The trend is said to be most common among the 30-49 age groups, when “the applicant doesn’t mind enriching his or her educational qualification,” says AuthBridge CEO, Ajay Trehan.
He goes on: “One candidate had furnished the educational qualifications of his ex-boss, another had used her deceased sister’s credentials while applying for a job.”
Pharma sector hiring grew by 24% last year compare with 2012, according to a report by headhunting firm Randstad. But most of the recent hires in senior positions are from outside the industry, noted a spokesperson for a large Indian pharma firm, because there is uncertainty about the quality of people available in the current market. In areas such as R&D, however, research and development, there are no options but to look for those within the industry. As a result, this particular executive’s firm has “tightened investigation of our potential employees.”
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Pfizer, GSK Gain ACIP Recommendations for RSV and Meningococcal Vaccines
April 18th 2025The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted to expand access to Pfizer’s respiratory syncytial virus vaccine Abrysvo for high-risk adults in their 50s and voted in favor of GSK’s meningococcal vaccine, Penmenvy, for streamlined adolescent protection.
